How tests and testing kits for coronavirus (COVID-19) work

AI Summary

This guidance issued by the UK Medicines and Healthcare products Regulatory Agency (MHRA) outlines the regulatory landscape for COVID-19 testing kits and medical devices within Great Britain. The document serves as a central resource for the public, healthcare professionals, and industry stakeholders to understand the operational mechanics and legal requirements of diagnostic tools. Although no specific company name or inspection dates are cited—as this is a general policy document rather than an enforcement letter—the framework focuses on compliance with In Vitro Diagnostic Medical Devices legislation and Great Britain's specific medical device regulations. Key sections detail the various types of COVID-19 tests, such as molecular and antigen assays, and the rigorous technical specifications manufacturers must achieve to ensure safety and accuracy. A significant portion of the guidance addresses the 'in-house' manufacture of medical devices, specifying that health institutions producing their own diagnostic tools must still adhere to high standards of quality management. Required actions for manufacturers include obtaining the necessary UK marking, providing clear instructions for use, and following strict post-market surveillance protocols. By consolidating these standards, the MHRA ensures that all testing kits available on the market meet the statutory requirements for clinical performance and user safety, maintaining public trust in the national diagnostic infrastructure.